Oligonucleotide
Salanersen
Own facility · Oligonucleotide
Investigational. This is an investigational compound and is not approved for marketing. Material and development services are offered only to qualified entities for research and pharmaceutical development, subject to applicable law.
Salanersen is an investigational antisense oligonucleotide for spinal muscular atrophy, designed as a longer-acting successor to earlier splicing-modulating ASOs.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| APIOligonucleotide | Own facility supply | n/a |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.